Triple

T15977910
Position Surface form Disambiguated ID Type / Status
Subject Suboxone E387494 entity
Predicate developedBy P73 FINISHED
Object Indivior
Indivior is a pharmaceutical company specializing in treatments for addiction and other serious mental health conditions.
 E1187595 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Indivior | Statement: [Suboxone, developedBy, Indivior]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Indivior
Context triple: [Suboxone, developedBy, Indivior]
  • A. Nicorette
    Nicorette is a leading nicotine replacement therapy brand offering products like gum, lozenges, and patches to help people quit smoking.
  • B. Suboxone
    Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
  • C. OxyContin
    OxyContin is a powerful prescription opioid painkiller, widely known for its role in the U.S. opioid epidemic and the controversies surrounding its marketing and abuse.
  • D. Vicodin
    Vicodin is a prescription painkiller that combines hydrocodone and acetaminophen, commonly used to treat moderate to severe pain and widely recognized from its depiction as Dr. Gregory House’s drug of choice.
  • E. Acomplia
    Acomplia is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Indivior
Triple: [Suboxone, developedBy, Indivior]
Generated description
Indivior is a pharmaceutical company specializing in treatments for addiction and other serious mental health conditions.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Indivior
Target entity description: Indivior is a pharmaceutical company specializing in treatments for addiction and other serious mental health conditions.
  • A. Nicorette
    Nicorette is a leading nicotine replacement therapy brand offering products like gum, lozenges, and patches to help people quit smoking.
  • B. Suboxone
    Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
  • C. OxyContin
    OxyContin is a powerful prescription opioid painkiller, widely known for its role in the U.S. opioid epidemic and the controversies surrounding its marketing and abuse.
  • D. Vicodin
    Vicodin is a prescription painkiller that combines hydrocodone and acetaminophen, commonly used to treat moderate to severe pain and widely recognized from its depiction as Dr. Gregory House’s drug of choice.
  • E. Acomplia
    Acomplia is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e157521f6c8190a54023b5ee6fc033 completed April 16, 2026, 9:40 p.m.
NED1 Entity disambiguation (via context triple) batch_69ffc3c76c988190a2f2bb4b6ac5ef25 completed May 9, 2026, 11:31 p.m.
NEDg Description generation batch_69ffc49bfa088190a6291f560ca9bdb5 completed May 9, 2026, 11:34 p.m.
NED2 Entity disambiguation (via description) batch_69ffc538a5f0819097ea09f57d3cae35 completed May 9, 2026, 11:37 p.m.
Created at: April 10, 2026, 4:54 a.m.